Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Eric Sherman, M.D.
Memorial Sloan Kettering Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic in Florida
Jacksonville, Florida, United States
- Northwestern University
Chicago, Illinois, United States
- Siouxland Regional Cancer Center
Sioux City, Iowa, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Nebraska Methodist Hospital
Omaha, Nebraska, United States
- Memorial Sloan Kettering Basking Ridge
Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth
Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen
Montvale, New Jersey, United States
- Memorial Sloan Kettering Commack
Commack, New York, United States
- Memorial Sloan Kettering Westchester
Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Memorial Sloan Kettering Sleepy Hollow
Sleepy Hollow, New York, United States
- Memorial Sloan Kettering Nassau
Uniondale, New York, United States
- Southeastern Medical Oncology Center-Clinton
Clinton, North Carolina, United States
- Southeastern Medical Oncology Center-Goldsboro
Goldsboro, North Carolina, United States
- Wayne Memorial Hospital
Goldsboro, North Carolina, United States
- Southeastern Medical Oncology Center-Jacksonville
Jacksonville, North Carolina, United States
- Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- Mercy Health System
Janesville, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Oct 2014
- Primary completion
- 28 Jan 2021
- Completion
- 6 Aug 2028
- Last update posted
- 11 Feb 2026
- Registered enrollment
- 35
- Registry id
- NCT02143726
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.